Industry update Ontario increases pot shop approvals to 30 a week Ontario's cannabis regulator says it's issued 489 store licences, with another 940 applications in the queue Jared GnamFebruary 16, 2021
Industry update Hexo to enter Europe with $265M Zenabis acquisition Hexo says the all-stock deal will gives it a top-3 spot in the Canadian cannabis market and a key foothold in Europe Jared GnamFebruary 16, 2021
Analysis Reddit traders send pot stocks to the moon — and back Cannabis stock spikes fueled by Reddit traders this week have little to do with fundamentals, says TradingView GM Pierce Crosby Jared GnamFebruary 12, 2021
Canada Redditor reveals BCLDB wholesale pricing, BC Cannabis Stores markup high as 117% Pricing depends on various factors including competition, a spokesperson says, who confirmed no customer data was leaked Nick LabaFebruary 12, 2021
Coming soon Vancouver considers reviewing Canada’s highest weed retail fees If a motion passes Feb. 18, city staff will review the $34,000 annual fee, which experts say will likely lead to a decreased payment Michelle GamageFebruary 11, 2021
Enforcement During Covid, California’s toxic trespass grows have returned to pre-legalization levels As enforcement efforts ebb, organizations like CROP are raising awareness and funds to reclaim the public wilderness Jesse KleinFebruary 11, 2021
Industry update CaaMTech close to winning patent to combine weed and psychedelics The Washington State-based biotech startup's application covers a range of cannabinoids and psilocybin compounds Jared GnamFebruary 10, 2021
Canada Listen to consumers and budtenders, not shareholders, says GTEC CEO Innovative firsts like listing terpene content on product labels is the result of keeping a close ear to the ground floor of the market Nick LabaFebruary 10, 2021
Industry update Tilray stock soars 40% on UK supply deal with Grow Pharma The BC-based producer continues global expansion flurry since unveiling merger deal with Aphira Jared GnamFebruary 9, 2021
Analysis Field Trip white paper makes strong health and business case for ketamine therapy With solid efficacy and low cost, the popular club drug could help curb the personal toll and multi-billion dollar cost of North America's battle... Natalia Buendia CalvilloFebruary 9, 2021